Literature DB >> 21091798

Profilin 1 overexpression in renal cell carcinoma.

Satoru Minamida1, Masatsugu Iwamura, Yoshio Kodera, Yusuke Kawashima, Masaomi Ikeda, Hiroshi Okusa, Tetsuo Fujita, Tadakazu Maeda, Shiro Baba.   

Abstract

OBJECTIVES: To gain information about overexpressed antigens in renal cell carcinoma (RCC) by using a chemical proteomics approach.
METHODS: RCC cell line 769P was cultured and proteome analysis was subsequently carried out in the culture supernatants. By using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and tandem mass spectrometry (LC-MS/MS), proteins in the culture supernatants were searched. A MEDLINE search to define the functions of the identified proteins was carried out.
RESULTS: Four differentially regulated proteins (profilin 1, amyloid beta A4 protein [APP], proprotein convertase subtilisin/kexin type 1 inhibitor [ProSAAS], galectin-3-binding protein [LGALS3BP]) were selected. These were not overexpressed in normal kidney tissue or reported in RCC. Their levels were measured through western blotting of normal kidney and RCC tissues. No differences were observed in the expression levels of APP, ProSAAS or LGALS3BP between RCC and normal kidney tissues. Profilin 1 was overexpressed in RCC tissue. On the basis of this observation, an immunohistochemical analysis of profilin 1 in normal kidney and RCC tissues was carried out. In normal tissues, tubules that were sources of RCC stained positive for profilin 1. In RCC tissue, in contrast, the stromal cells in the tumors stained positive.
CONCLUSIONS: Profilin 1 can be a key element in the pathological processes of RCC, such as tumorigenesis and/or tumor growth. Thus, it has the potential to serve as a diagnostic or progression biomarker and therapeutic target in RCC.
© 2010 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091798     DOI: 10.1111/j.1442-2042.2010.02670.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  12 in total

Review 1.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

2.  Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.

Authors:  Abigail Allen; David Gau; Paul Francoeur; Jordan Sturm; Yue Wang; Ryan Martin; Jodi Maranchie; Anette Duensing; Adam Kaczorowski; Stefan Duensing; Lily Wu; Michael T Lotze; David Koes; Walter J Storkus; Partha Roy
Journal:  J Biol Chem       Date:  2020-09-03       Impact factor: 5.157

3.  Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.

Authors:  Ya-Jun Cheng; Zhen-Xin Zhu; Jian-Sheng Zhou; Zun-Qi Hu; Jian-Peng Zhang; Qing-Ping Cai; Liang-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

4.  Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.

Authors:  Joëlle V F Coumans; David Gau; Anne Poljak; Valerie Wasinger; Partha Roy; Pierre D J Moens
Journal:  OMICS       Date:  2014-12

5.  Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.

Authors:  Xue-Ling Kang; Hong Zou; Li Juan Pang; Wen Hao Hu; Jin Zhao; Yan Qi; Chun-Xia Liu; Jian Ming Hu; Jing-Xia Tang; Hong An Li; Wei Hua Liang; Xiang-Lin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

6.  From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.

Authors:  Toni K Choueiri; Laurence Albiges; Michael B Atkins; Ziad Bakouny; Gennady Bratslavsky; David A Braun; Naomi B Haas; John B A G Haanen; A Ari Hakimi; Michael A S Jewett; Eric Jonasch; William G Kaelin; Payal Kapur; Chris Labaki; Bryan Lewis; David F McDermott; Sumanta K Pal; Kevin Pels; Susan Poteat; Thomas Powles; W Kimryn Rathmell; Brian I Rini; Sabina Signoretti; Nizar M Tannir; Robert G Uzzo; Hans J Hammers
Journal:  Clin Cancer Res       Date:  2022-03-01       Impact factor: 13.801

7.  Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.

Authors:  Olena Masui; Nicole M A White; Leroi V DeSouza; Olga Krakovska; Ajay Matta; Shereen Metias; Bishoy Khalil; Alexander D Romaschin; R John Honey; Robert Stewart; Kenneth Pace; Georg A Bjarnason; K W Michael Siu; George M Yousef
Journal:  Mol Cell Proteomics       Date:  2012-10-17       Impact factor: 5.911

8.  Poly(I:C) treatment influences the expression of calreticulin and profilin-1 in a human HNSCC cell line: a proteomic study.

Authors:  Tanja Matijević; Jasminka Pavelić
Journal:  Tumour Biol       Date:  2012-03-14

Review 9.  Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.

Authors:  Debasish Paul; Avinash Kumar; Akshada Gajbhiye; Manas K Santra; Rapole Srikanth
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

10.  Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity.

Authors:  Sascha Kopp; Elisabeth Warnke; Markus Wehland; Ganna Aleshcheva; Nils E Magnusson; Ruth Hemmersbach; Thomas Juhl Corydon; Johann Bauer; Manfred Infanger; Daniela Grimm
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.